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Abstract
Background and purposes: To compare the dosimetry for the left-sided breast cancer treatment using five
different radiotherapy techniques.
Materials and methods: Twenty patients with left sided breast cancer were treated with conservative surgery
followed by radiotherapy. They were planned using five different radiotherapy techniques, including: 1) conventional
tangential wedge-based fields (TW); 2) field-in-field (FIF) technique; 3) tangential inverse planning intensity-modulated
radiation therapy (T-IMRT); 4) multi-field IMRT (M-IMRT); and 5) volumetric modulated arc therapy (VMAT). The CTV,
PTV and OARs including the heart, the regions of coronary artery (CA), the contralateral breast, the left and
right lung were delineated. The PTV dose was prescribed 50Gy and V47.5≥95%. Same dose constraint was used
for all five plans. The planned volumetric dose of PTV and PRV-OARs were compared and analyzed.
Results: Except VMAT (Average V47.5 was 94.72%±1.2%), all the other four plans were able to meet the V95%
(V47.5) requirement. T-IMRT plan improved the PTV dose homogeneity index (HI) by 0.02 and 0.03 when
compared to TW plan and VMAT plan, and decreased the V5, V10 and V20 of all PRV-OARs. However, the high
dose volume (≥ 30Gy) of the PRV-OARs in T-IMRT plan had no statistically significant difference compared with
the other two inverse plans. In all five plans, the dose volume of coronary artery area showed a strong
correlation to the dose volume of the heart (the correlation coefficients were 0.993, 0.996, 1.000, 0.995 and
0.986 respectively).
Conclusion: Compared to other techniques, the T-IMRT technology reduced radiation dose exposure to normal
tissues and maintained reasonable target homogeneity, VMAT is not recommended for left-sided breast cancer
treatment. In five techniques, the dose-volume histogram (DVH) of the heart can be used to predict the dose-volume
histogram (DVH) of the coronary artery.
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Introduction
Many studies on comparison of dose distribution for
breast cancer radiotherapy techniques have been re-
ported [1-5]. In these studies, the comparative irradi-
ation techniques mainly include [2-6]: 1) conventional
tangential wedge fields (TW), 2) field-in-field (FIF), 3)
tangential fields inverse intensity-modulated radiation
therapy (T-IMRT), 4) multi-field IMRT (M-IMRT) and
5) irregular surface compensator (ISC). Recently, a new
technique known as volumetric modulated arc therapy
(VMAT) has been introduced. Compared to the trad-
itional forward planning, the inverse-planned modu-
lated irradiation therapy may benefit in better target
dose homogeneity index (HI) and PRV-OARs dose
reduction [5,6].
The technologies mentioned above have been imple-
mented in many institutions in China [7,8]. Although
the T-IMRT is reported having better target dose homo-
geneity and sparing normal tissue such as the heart and
the ipsilateral lung, there are still some aspects of con-
cern. Firstly, the planning target volume (PTV) of Chinese
patients, which maximum and mean volume of 589.77cc
and 427.2 cc reported by Huang [9] are obviously smaller
than the Caucasians one with the maximum and the mean
volume of 2170 cc and 994 cc as reported by Popescu [10].
This may lead to different results in using various irradiat-
ing techniques. Secondly, for irradiation of the left breast,
cardiac dose is one of the most important issues. The
most serious radiation induced complication of the heart
is coronary artery injury [11]. Currently reported literature
mainly [12-15] focused on the volumetric dose of the
heart, but few studies concentrated on the coronary artery
region specifically. Xu et al [15] conjectured the cardiac
dose might be associated with the breast volume for whole
left breast irradiation. In their report IMRT treatment
could significantly reduce cardiac dose for those clinical
target volume (CTV) larger than 500 cc compared with
conventional tangential techniques. In our study, we spe-
cifically compared the coronary artery dose of various ra-
diation treatment techniques for the Chinese patient
which having relative smaller PTV. Moreover, Popescu
CC et al [16] reported that VMAT was able to improve
dosimetry and reduce treatment time compared to con-
ventional intensity modulated radio- therapy for loco-
regional radiotherapy of left-sided breast cancer and
internal mammary nodes. Whether VMAT offers dose
benefits for whole left breast irradiation is another issue of
our interest.
In this study, it is aimed to give some advice about the
individual irradiation therapy to the patients after left
conservative surgery whose planning target volume was
relative smaller based on the dose comparison of five ra-
diation methods and the irradiated dose analysis of plan-
ning target volume and OARs.
Material and methods
Twenty patients with left-sided breast cancer were ran-
domly selected for this treatment planning study. They
have undergone breast-conserving surgery.
Target and normal tissue delineation
CTV and PTV for the breast were delineated according
to the recommendation of ICRU report #83. The breast
CTV included all visible breast parenchyma. The PTV
was added a 7-mm expansion in all direction around the
CTV except the skin surface, including the set-up margin
and patient movement. The CTV of all the 20 cases were
delineated by the same radiation oncologist based on CT
image. The maximum volume of PTV was 586.4 cc, the
smallest was 132.6 cc and the average was 360.8±149.1 cc.
The PRV contours of all the involved OARs, including
contra-lateral breast, entire heart, coronary artery area
(CA), left lung and right lung were outlined by the treating
physician. All targets and PRVs were outlined slice by slice
of the CT image in the treatment planning system and
then reconstructed the three dimensional contour auto-
matically. Figure 1 shows the PTV and PRV-OARs.
The coronary artery most commonly affected by radi-
ation is the left anterior descending, followed by the right
branch and left circumflex [17]. Thus, the area of left front
one-fourth heart 1cm subsurface can be identified as the
volume of coronary artery part according to the American
Memorial Sloan-Kattering cancer research methods [3].
Plan design
All plans were completed in three-dimensional treat-
ment planning system (Pinnacle 9.0 m, ADAC, Philips).
The TPS determined homogeneous media and density
in the body based on the CT density calibration curve
and calculated dose with Collapse Cone convolution,
which taken account of the calibration of inhomogen-
eous medium [18]. The Elekta Synergy linear accelerator
with 6MV photon energy was used. The PTV was pre-
scribed to 50Gy (D50%) and the optimization constraint
is that ensuring 95% isodose line encompasses 95% of
PTV (V95%≥47.5Gy).
Figure 1 An example of the contour of PTV and PRV-OARs.
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The TW plan used two opposite half beam which had an
appropriate wedge angle and included the whole PTV. The
FIF plan and T-IMRT plan were created with same beam
angle of the conventional TW plan. The FIF plan had 3–5
subfields on each side using the multileaf collimators to
ensure the Dmax of PTV not more than 52.5Gy.
As 7-beam or 9-beam plan was reported to be more
appropriate for M-IMRT [19], the 7-beam plan which
avoided direct exposure to the contralateral breast was
selected in this study.
VMAT which arc direction is such that beam enters
the breast before exiting through the lung may increase
the dose volume of the lung and contralateral breast.
For example, in our peer study, we found that VMAT
with a partial arc could reduce the lower dose (≤10) vol-
ume of left lung nearly to 5% compared to VMAT with
a full arc. So in this paper, the VMAT plan used an arc
field which starting angle and ending angle were respect-
ively the same as the tangential beam angle, and the de-
gree of the sub-field interval of 4° was used [20].
For the IMRT and VMAT plans, the optimization ob-
jective listed in Table 1 was used. Direct machine param-
eter optimization (DMPO) was applied to optimize
plans. The minimum field size and monitor unite of
sub-field was restricted as 2 cm2 and 2 MU.
Ethical considerations
The different treatment techniques have been applied to
the patients’ dataset without any clinical application. This
activity does not require an ethical approval according to
our institution’s rules.
Data analysis
The conformity index (CI) and homogeneity index (HI)
were defined to describe the quality of plans as follows:
1) CI=V47.5Gy/PTV, V47.5Gy represent the volume receiv-
ing 47.5Gy, 2) HI= (D2% -D98%)/D50%, D2%, D50% and D98%
mean the doses of 2%, 50% and 98% volume of the PTV.
The results difference between any two of the five
plans were compared and analyzed with ANOVA test
(α=0.05) using SPSS 17.0 software.
Planned dose results
As showed in Table 2, except the VMAT plan, all the
other four plans were able to meet the PTV dose prescrip-
tion of V95%≥47.5Gy. The 7-IMRT had the best CI (1.3).
FIF, 7-IMRT and VMAT plans had the smallest HI (0.11).
Dose of planning target volume (PTV)
The PTV47.5 of VMAT could not meet the planned dose
constraint. In ANOVA comparison with each other plan,
The CI of 7-IMRT and VMAT plan was smaller than the
TW and FIF plan (p<0.05), but the difference of CI among
the three inverse plans had no statistical significant. With
respect to the HI of PTV, FIF and 7-IMRT plan had similar
value of T-IMRT (p>0.05) between any two, but TW and
VMAT plans were significantly worse (p<0.05). Figure 2
shows the dose distribution of five plans in isocentral slice.
Left lung
Table 3 shows the Dmean and Vd of the left lung in differ-
ent treatment techniques. The test results showed that
the T-IMRT plan reduced the average dose and dose-
volume except V40 compared with other plans. V40 of
the three inverse plans were lower than TW and FIF
plans significantly (p<0.05). However, the average V40
between any two of the three inverse plans had no statis-
tical difference (p>0.05).
Heart and coronary arteries
For the whole heart area, the average mean dose and
V5~V20 of T-IMRT plan were smaller than all other
plans significantly except FIF plan (P<0.05). The average
V30 and V40 of three inverse plans were smaller than
TW and FIF plans (P<0.05), and the difference between
any two of the three inverse plans was similar (p>0.05).
The inverse plans also reduced the average mean dose
and the V10~V40 of the coronary arteries compared to
other two plans (p<0.05), and the difference of the three
inverse plans was not statistical significant between any
two (p>0.05). The V5 of T-IMRT plan was the smallest
among the five plans (p<0.05).
Table 1 The optimization objective used for inverse IMRT
planning
Structure Planning aim
PTV V52Gy≤1%, V51Gy≤ 4%; D50% = 50Gy;
V49Gy≥ 100%,V50Gy ≥ 95%
PRV-contralateral breast Dmax ≤ 3Gy
PRV-left lung V10Gy≤ 30%; V20Gy≤ 20%; V30Gy≤ 10%
PRV-coronary artery region V10Gy≤ 25%, V20Gy≤ 15%, V30Gy≤ 5%
PRV-heart V10Gy≤ 20%; V20Gy≤ 15%; V30Gy≤ 20%
Table 2 The PTV dose parameters of five plans (x ± d)
Parameters TW FIF T-IMRT 7-IMRT VMAT
D98(Gy) 47.3±0.4 47.0±0.4 47.0±0.6 47.3±0.6 46.4±0.6
D2(Gy) 53.2±0.6 52.0±0.6 52.7±0.6 52.4±0.5 53.4±0.7
D50(Gy) 50.6±0.6 50.7±0.4 50.7±0.4 50.4±0.4 51.0±0.4
V95% 96.2±1.6A 95.6±1.6A 96.8±1.7A 96.1±1.7A 94.7±1.2A
CI 2.0±0.5Aa 1.7±0.4A 1.6±0.3Ab 1.3±0.1Bb 1.4 ±0.2Bb
HI 0.13±0.02A 0.11±0.02B 0.11±0.03B 0.11±0.02B 0.14±0.02A
A had significant difference with B (p<0.05), and, a had significant difference with b
(p<0.05). Otherwise the difference was not significant between any two (p>0.05).
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Details of dose difference in PRV-heart and PRV-
coronary artery were listed in Tables 4 and 5.
Contralateral breast
The planned dose parameters of PRV-contralateral breast
were listed in Table 6. It could be found that the average
mean dose and V2~V4 of three tangential plans were
lower than the other two plans (p<0.05), and the differ-
ence between any two of the three tangential plans was
not statistical significant. The V5 of VMAT plan was the
maximum of all five plans (p<0.05) and the difference of
other four plans was not statistical significant. The V10 of
five plans were all very small and were not significantly
different between any two.
Discussion
There have been many reports about the choice of radia-
tion treatment technique for breast cancer after conserv-
ing surgery. Even in Rongsriyam’s report [21], T-IMRT
should be the best treatment. However, Bhanagar A.K
et al [22] found that the size of primary breast signifi-
cantly affect the scatter dose to the contra-lateral breast.
Figure 2 The dose distribution of five plans in isocenter slice.
Table 3 Dose comparison of the PRV-left lung between
the five plans (x ± d)
Parameters TW FIF T-IMRT 7-IMRT VMAT
Dmean(Gy) 8.6±2.6
A 8.2±2.4A 6.8±2.0Ba 9.3±3.8A 10.1±2.5Bb
V5 (%) 25.9±6.6
A 24.6±6.1A 23.4±5.6A 49.4±9.5B 50.3±13.3B
V10 (%) 20.9±5.9
A 19.1±5.5A 17.7±4.9A 26.8±6.2B 29.9±8.0B
V20 (%) 16.9±5.4
Ab 15.0±5.0A 12.9±4.2Aa 14.6±4.5A 16.4±4.8Ab
V30 (%) 14.2±5.1
B 12.2±4.6A 9.6±3.9A 9.6±3.9A 10.3±3.4A
V40 (%) 10.9±4.6
A 8.7±3.9A 6.3±3.2B 4.7±2.5B 5.1±2.4B
A had significant difference with B (p<0.05), and, a had significant difference
with b (p<0.05). Otherwise the difference was not significant between any
two (p>0.05).
Table 4 Comparison of the PRV-heart dose parameters in
five plans (x ± d)
Parameters TW FIF T-IMRT 7-IMRT VMAT
Dmean(Gy) 3.7±2.0
Ab 3.2±1.9A 2.2±1.0Aa 4.4±1.9Ab 4.6±1.7Ab
V5 (%) 10.2±6.0
A 8.9±5.9A 6.3±3.6A 26.2±21.1B 26.1±15.1B
V10 (%) 7.5±5.0
Aa 6.1±4.8A 3.5±2.4Ab 6.8±5.4Aa 6.9±4.9Aa
V20 (%) 5.6±4.2
A 4.3±4.0A 2.0±1.7Bb 2.1±2.1Bb 2.5±2.4Ba
V30 (%) 4.2±3.5
A 3.2±3.3A 1.2±1.3B 1.0±1.3B 1.1±1.5B
V40 (%) 3.0±2.7
A 2.0±2.2A 0.6±0.9B 0.3±0.7B 0.4±1.0B
A had significant difference with B (p<0.05), and, a had significant difference
with b (p<0.05). Otherwise the difference was not significant between any
two (p>0.05).
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The PTV size of Chinese patients was smaller com-
pared to those of the Caucasians. The mean and max-
imum size of PTV in our study was nearly one fourth
to one third of those reported by Popescu CC. et al [10].
With respect to the dose parameters of PTV in this study,
T-IMRT plan had obvious advantages on the HI than TW
plan and VMAT plan, but it was not superior to the FIF
plan and 7-IMRT plan when strict limitation was applied
to the CI. In addition, T-IMRT plan had worse CI than
7-IMRT. This was different from the reported results of
Jagsi et al [23], which might be the influence of the PTV
size between European and Chinese. The multi-field plan
and VMAT plan reduced the high dose-volume of PRV-
OARs but increased the low dose-volume, and the VMAT
plan even could not meet the constraint of PTV95%≥95%.
To better conclude the most superior technique from the
multi-parameter results of our study, we use the following
score table to help making the evaluation. In the score
table, it is scored to point 1 if the difference showed sig-
nificant advance between the compared parameters,
otherwise scored to 0. Thus, the best treatment technique
goes to the one having highest score in the Table 7.
From the summary of scoring, T-IMRT has the most
point of 26 which is almost 2 time of each all other tech-
nique. Although the PTV size was much smaller in this
study, the score table led to similar result with the
reported study of western cases. Caudell JJ.et al [24] reported that electronic compensation (CE) technique
produced superior dose distribution in both CTV and
normal tissue compared with conventional T-IMRT.
One can expect that the dose distribution could be even
better if CE technique was integrated.
The application of IMRT offers the potential for im-
proved local-regional control without increase heart tox-
icity in those requiring local-regional treatments [25].
Darby SC et al. reported that exposure of the heart to
ionizing radiation during radiotherapy for breast cancer
increases the subsequent rate of ischemic heart disease
[26]. Most of the literature analyzed the irradiated dose
of heart, but they did not specify the dosimetric parame-
ters of coronary artery when comparing the dose diffe-
rence of treatment plans for the left-side breast cancer
Table 5 Planned dose of PRV-coronary artery in five
plans (x ± d)
Parameters TW FIF T-IMRT 7-IMRT VMAT
Dmean(Gy) 19.4±10.9
A 15.5±10.2A 8.9±5.2B 9.9±4.7B 11.0±4.6B
V5 (%) 63.9±26.9
A 56.8±26.8Aa 46.2±21.9B 66.2±28.2A 82.0±23.3Ab
V10 (%) 52.0±28.3
A 42.4±24.6Ba 25.6±17.8Bb 28.6±18.3Bb 35.2±20.7B
V20 (%) 40.9±27.1
A 31.2±26.6A 12.4±14.6B 11.9±14.5B 12.9±14.3B
V30 (%) 32.2±25.5
A 23.5±25.0A 6.4±10.6B 5.5±9.9B 4.5±8.7B
V40 (%) 22.3±33.0
A 14.3±19.9A 2.6±5.9B 1.3±4.0B 1.5±6.2B
A had significant difference with B (p<0.05), and, a had significant difference with b
(p<0.05). Otherwise the difference was not significant between any two (p>0.05).
Table 6 The dose parameters of PRV-coronary artery of
five plans (x ± d)
Parameters TW FIF T-IMRT 7-IMRT VMAT
Dmean(Gy) 0.4±0.4
A 0.4±0.4A 0.4±0.3A 1.6±0.7B 1.9±1.0B
V2 (%) 1.7±3.6
A 2.2±3.9A 1.5±2.9A 29.4±21.2B 33.1±29.9B
V3 (%) 0.6±1.9
A 0.6±2.0A 0.2±0.6A 13.9±15.2B 15.2±22.1B
V4 (%) 0.4±1.5
A 0.4±1.6A 0.1±0.3A 5.8±8.1Ba 7.5±13.0Bb
V5 (%) 0.3±1.3
A 0.3±1.4A 0.0±0.2A 1.6±3.2A 4.0±7.5B
V10 (%) 0.2±0.9
A 0.2±0.9A 0.0±0.0A 0.0±0.0A 0.0±0.0A
A had significant difference with B (p<0.05), and, a had significant difference
with b (p<0.05). Otherwise the difference was not significant between any
two (p>0.05).
Table 7 Score table of the five treatment techniques
Structure Doseparameter
Treatment technique
TW FIF TIMRT 7IMRT VMAT
PTV HI 1 1 1 1 0
CI 0 0 1 1
V47.5 1 0 1 1 0
PRV-l- lung
Dmean 0 1 0 0
V5 1 1 1 0 0
V10 1 1 1 0 0
V20 0 0 1 0 0
V30 0 1 1 1 1
V40 0 0 1 1
PRV-Heart
Dmean 0 1 1 0 0
V5 1 1 1 0 0
V10 0 1 0 0
V20 0 0 1 1 1
V30 0 0 1 1 1
V40 0 0 1 1 1
PRV-coronary artery
Dmean 0 0 1 1 1
V5 0 1 0 0
V10 0 1 1 1
V20 0 0 1 1 1
V30 0 0 1 1 1
V40 0 0 1 1 1
PRV-r-breast
Dmean 1 1 1 0 0
V2 1 1 1 0 0
V3 1 1 1 0 0
V4 1 1 1 0 0
V5 1 1 1 0 0
V10 1 1 1 1 1
Score 10 12 26 14 12
The blank scoring: one who cannot be judged as superior nor inferior since it
was not significant differ from both (p>0.05).
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Figure 3 The relationship between in dose volume of heart and coronary artery. The abscissa and ordinate respectively represent the dose
volume of heart and coronary artery. The red curve is the fitting curve.
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after conserving surgery. There were some studies sug-
gested that coronary heart disease after postoperative
radiotherapy for breast cancer was one of the radiation-
related complications [27,28]. In this study, the dose-
volume (V5Gy~V40Gy) of heart and coronary artery were
detailed and their relationships were described with the
quadratic polynomial. Figure 3 shows respectively the
dose volume correlation of heart and coronary artery of
the five plans. The correlation coefficients were 0.993
(TW), 0.996 (FIF), 0.9972 (T-IMRT), 0.995 (7-IMRT) and
0.986 (VMAT). This could be helpful to use the dose-
volume of heart to predict the dose-volume of coronary
artery. For example, if the V30Gy of heart is 10% in
T-IMRT, the V30Gy of coronary artery can be calculated as
76.41% with the relation coefficient in Figure 3c). Dose-
volume evaluation of coronary artery can be included in
the constraint of heart dose. This was similar to the find-
ings of other reports [29], which suggested to predict the
dose of CA but not figured out the relationship in
between.
Various reports have shown that the incidence of sec-
ond cancer risk would increase with the increasing of
the irradiated dose of contralateral breast [3]. Although
7-IMRT and VMAT were planned with same dose con-
straint for contralateral breast as the other techniques,
the V2~V5 of contralateral breast were significant higher
than the other three plans.
There are some reports about the application of
VMAT in the clinical treatment of intact breast treat-
ment with or without nodal involvement as well as for
partial breast treatment [16]. In our study, the average
MU of VMAT plan (363.7±45.3) was significantly
smaller (P<0.05) than that of 7-IMRT (513.4±83.3MU).
VMAT technique was superior in the irradiation MUs
compared to 7-IMRT. Also, VMAT plan had apparent
advantages in reducing the volume of high dose and
drawbacks in increasing the volume of lower dose.
In our study, Comparing to the three tangential treat-
ments VMAT reduced the normal tissue volume receiv-
ing high dose but significantly increased the volume of
low dose. Especially, the average PTV95% of the 20 cases
was worse than 95% when planned with same optimiza-
tion objective of other treatment techniques. Consider-
ing the risk of tumor recurrence and the relative high
dose in lung and contralateral breast, we do not suggest
to choose VMAT for left-sided breast cancer radiation
therapy.
Conclusion
According to the data of our study, for the breast cancer
patient whose PTV is rather smaller than western popu-
lation, the size of primary breast do not significantly in-
crease the dose of contra-lateral breast as reported by
Bhanagar [22], and T-IMRT is still an adequate tech-
nique for the Chinese patients who undergo conserving
breast surgery. For planning for left-breast irradiation,
the volumetric dose of the heart which is more easy to
be contoured can be used to predict the volumetric dose
of coronary artery, if the relationship in between is well
fitted. VMAT plan had a few advantage in improving the
HI of PTV but may decrease the PTV dose coverage
and increase the dose irradiate to lung and contra-lateral
breast. The T-IMRT plan may be clinically.
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